Cargando…
Urinary Biomarkers in Monitoring the Progression and Treatment of Autosomal Dominant Polycystic Kidney Disease—The Promised Land?
Autosomal dominant polycystic kidney disease (ADPKD) is the most common genetic kidney disease, and it leads to end-stage renal disease (ESRD). The clinical manifestations of ADPKD are variable, with extreme differences observable in its progression, even among members of the same family with the sa...
Autores principales: | Pana, Camelia, Stanigut, Alina Mihaela, Cimpineanu, Bogdan, Alexandru, Andreea, Salim, Camer, Nicoara, Alina Doina, Resit, Periha, Tuta, Liliana Ana |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10224545/ https://www.ncbi.nlm.nih.gov/pubmed/37241147 http://dx.doi.org/10.3390/medicina59050915 |
Ejemplares similares
-
Hypoxia-Inducible Factors and Diabetic Kidney Disease—How Deep Can We Go?
por: Stanigut, Alina Mihaela, et al.
Publicado: (2022) -
Efficiency of Platelet Transfusion in Patients with Moderate-to-Severe Chronic Kidney Disease and Thrombocytopenia
por: Ali, Sevigean, et al.
Publicado: (2023) -
Autosomal dominant polycystic kidney
por: Gudadhe, Rugaved Raghavendra, et al.
Publicado: (2022) -
A single-arm pilot study of metformin in patients with autosomal dominant polycystic kidney disease
por: Sorohan, Bogdan Marian, et al.
Publicado: (2019) -
Autosomal dominant polycystic kidney disease in Colombia
por: Camargo, Jessica T., et al.
Publicado: (2023)